Immunologic tests detect hidden prostate cancer

	Tweet

In patients with locally advanced prostate cancer and negative results on lymph node examination, immunochemical testing of the lymph node cells can spot the spread of cancer cells that are not detected at initial tissue examination, a study shows.

Moreover, the presence of hidden prostate cancer cells that have spread (metastasized) to the lymph nodes increases the risk of recurrence and death, the study investigators report in the Journal of Clinical Oncology.

Therefore, when hidden lymph node metastases are detected in patients with locally advanced prostate cancer, “our results suggest they should be treated as high-risk patients,” advise Dr. Richard J. Cote and colleagues from the University of Southern California in Los Angeles. 

They studied 274 patients with locally advanced prostate cancer who underwent surgery to remove the prostate and had cell samples taken from the lymph nodes in the groin, a common site of cancer metastases. Of these patients, 180 were diagnosed with lymph node-negative disease based on the results of routine tissue examination.

A total of 3,914 lymph nodes from the node-negative patients, an average of 21.7 nodes per patient, were then evaluated for hidden metastases using immunochemical methods, which looked for prostate-specific antigen (PSA) and certain antibodies associated with this cancer.

The results revealed hidden tumor cells in 24 patients (13.3 percent), according to the team.

Compared with patients without hidden tumor cells in the lymph nodes, the presence of these cells more than doubled the risk of prostate cancer recurrence and mortality.

These findings may have “profound implications” for the early initiation of systemic treatment after prostate cancer surgery in patients with localized prostate cancer and whose lymph nodes appear to be negative using routine tissue analysis, Cote and colleagues conclude.

SOURCE: Journal of Clinical Oncology, June 20, 2006.

RELATED STORIES:
Minimally invasive breakthrough for men’s enlarged prostates improves symptoms   Chlordecone exposure and risk of prostate cancer   No link seen between coffee, prostate cancer risk   Prostate cancer patients disease free after 5 years likely to be disease free after 10 years   Hops Compound May Prevent Prostate Cancer   Dutasteride useful for enlarged prostate   Possible link found between x-rays and prostate cancer   Green Tea May Affect Prostate Cancer Progression   Prostate Cancer Grading & Staging   Men Who Take Aspirin Have Significantly Lower PSA Levels   Age alone should not be used to determine whether to treat prostate cancer with hormones   Finnish researchers find a compound that prevents the growth of prostate cancer cells   Prostate cancer patients are at increased risk of precancerous colon polyps   Severe Form of “Enlarged Prostate” Disease Discovered   Stem Cells Found in Prostate May Be Involved in Cancer   Scientists Find Second Site for Prostate Cancer Gene   On Sex After Prostate Surgery, Confusing Data   Prostate Cancer Surgeons “Feel” With Their Eyes   ARRA Funds Research to Improve Prostate Cancer Identification   Researchers Uncover How Prostate Cancer Cells Defy Death   Mushroom extract may boost prostate cancer drug   Family history of prostate cancer does not affect some treatment outcomes

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]